NO963949L - Amidderivater av vitamin D - Google Patents
Amidderivater av vitamin DInfo
- Publication number
- NO963949L NO963949L NO963949A NO963949A NO963949L NO 963949 L NO963949 L NO 963949L NO 963949 A NO963949 A NO 963949A NO 963949 A NO963949 A NO 963949A NO 963949 L NO963949 L NO 963949L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- group
- sec
- alpha
- hydrogen atom
- Prior art date
Links
- 229930003316 Vitamin D Natural products 0.000 title abstract 2
- -1 Vitamin D amide Chemical class 0.000 title abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title abstract 2
- 235000019166 vitamin D Nutrition 0.000 title abstract 2
- 239000011710 vitamin D Substances 0.000 title abstract 2
- 229940046008 vitamin d Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000000125 calcaemic effect Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9405715A GB9405715D0 (en) | 1994-03-23 | 1994-03-23 | Chemical compounds |
| PCT/GB1995/000658 WO1995025718A1 (en) | 1994-03-23 | 1995-03-23 | Vitamin-d amide derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO963949D0 NO963949D0 (no) | 1996-09-20 |
| NO963949L true NO963949L (no) | 1996-11-22 |
| NO309188B1 NO309188B1 (no) | 2000-12-27 |
Family
ID=10752346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO963949A NO309188B1 (no) | 1994-03-23 | 1996-09-20 | Amidderivater av vitamin D, anvendelse, preparater samt fremgangsmåte for fremstilling derav |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5811562A (no) |
| EP (1) | EP0751932B1 (no) |
| JP (1) | JP3790544B2 (no) |
| KR (1) | KR100361556B1 (no) |
| CN (1) | CN1073557C (no) |
| AT (1) | ATE181063T1 (no) |
| AU (1) | AU685249B2 (no) |
| CA (1) | CA2185813A1 (no) |
| CZ (1) | CZ290304B6 (no) |
| DE (1) | DE69510189T2 (no) |
| DK (1) | DK0751932T3 (no) |
| ES (1) | ES2132651T3 (no) |
| FI (1) | FI112359B (no) |
| GB (1) | GB9405715D0 (no) |
| GR (1) | GR3031084T3 (no) |
| HU (1) | HUT75520A (no) |
| IL (1) | IL113113A (no) |
| NO (1) | NO309188B1 (no) |
| NZ (1) | NZ282453A (no) |
| WO (1) | WO1995025718A1 (no) |
| ZA (1) | ZA952377B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19619036A1 (de) | 1996-04-30 | 1997-11-13 | Schering Ag | Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| US6043385A (en) * | 1997-12-16 | 2000-03-28 | Hoffman-La Roche Inc. | Vitamin D derivatives |
| DE19935771A1 (de) * | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| AU2005201074B2 (en) * | 1999-08-17 | 2007-10-18 | Battelle Memorial Institute | A Chemical reactor and method for gas phase reactant catalytic reactions |
| DE60021086T2 (de) * | 1999-08-17 | 2006-05-04 | Battelle Memorial Institute, Richland | Chemischer reaktor und verfahren zur katalytischen gasphasenreaktionen |
| US6989377B2 (en) | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
| US6358939B1 (en) | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| JP4269144B2 (ja) | 2000-10-02 | 2009-05-27 | エモリー ユニバーシティ | 自己免疫疾患および炎症障害の処置のためのトリプトリドアナログ |
| EA201691980A1 (ru) | 2009-01-27 | 2017-07-31 | БЕРГ ЭлЭлСи | Способы уменьшения побочных эффектов, связанных с химиотерапией |
| CN102655869B (zh) | 2009-08-14 | 2016-08-10 | 博格有限责任公司 | 用于治疗脱发的维生素d3及其类似物 |
| WO2014194133A1 (en) | 2013-05-29 | 2014-12-04 | Berg Llc | Preventing or mitigating chemotherapy induced alopecia using vitamin d |
| JP7644444B2 (ja) * | 2021-03-02 | 2025-03-12 | 学校法人東京理科大学 | 異性体調製装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0614455B1 (en) * | 1991-11-07 | 1996-02-21 | Research Institute For Medicine And Chemistry Inc. | Vitamin d amide derivatives |
| GB9206648D0 (en) * | 1992-03-26 | 1992-05-06 | Leo Pharm Prod Ltd | Chemical compounds |
| DE4234382A1 (de) * | 1992-10-06 | 1994-04-07 | Schering Ag | 25-Carbonsäure-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
| GB9309422D0 (en) * | 1993-05-07 | 1993-06-23 | Res Inst Medicine Chem | Chemical compounds |
-
1994
- 1994-03-23 GB GB9405715A patent/GB9405715D0/en active Pending
-
1995
- 1995-03-23 DE DE69510189T patent/DE69510189T2/de not_active Expired - Fee Related
- 1995-03-23 CN CN95192735A patent/CN1073557C/zh not_active Expired - Fee Related
- 1995-03-23 US US08/704,613 patent/US5811562A/en not_active Expired - Fee Related
- 1995-03-23 IL IL11311395A patent/IL113113A/en not_active IP Right Cessation
- 1995-03-23 EP EP95912345A patent/EP0751932B1/en not_active Expired - Lifetime
- 1995-03-23 JP JP52450395A patent/JP3790544B2/ja not_active Expired - Fee Related
- 1995-03-23 ZA ZA952377A patent/ZA952377B/xx unknown
- 1995-03-23 HU HU9602572A patent/HUT75520A/hu unknown
- 1995-03-23 WO PCT/GB1995/000658 patent/WO1995025718A1/en not_active Ceased
- 1995-03-23 CZ CZ19962660A patent/CZ290304B6/cs unknown
- 1995-03-23 AT AT95912345T patent/ATE181063T1/de not_active IP Right Cessation
- 1995-03-23 KR KR1019960705257A patent/KR100361556B1/ko not_active Expired - Fee Related
- 1995-03-23 ES ES95912345T patent/ES2132651T3/es not_active Expired - Lifetime
- 1995-03-23 DK DK95912345T patent/DK0751932T3/da active
- 1995-03-23 CA CA002185813A patent/CA2185813A1/en not_active Abandoned
- 1995-03-23 NZ NZ282453A patent/NZ282453A/en unknown
- 1995-03-23 AU AU19560/95A patent/AU685249B2/en not_active Ceased
-
1996
- 1996-09-20 FI FI963754A patent/FI112359B/fi not_active IP Right Cessation
- 1996-09-20 NO NO963949A patent/NO309188B1/no unknown
-
1999
- 1999-08-26 GR GR990402167T patent/GR3031084T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69510189T2 (de) | 1999-11-11 |
| AU685249B2 (en) | 1998-01-15 |
| ES2132651T3 (es) | 1999-08-16 |
| KR100361556B1 (ko) | 2003-02-17 |
| AU1956095A (en) | 1995-10-09 |
| EP0751932A1 (en) | 1997-01-08 |
| JP3790544B2 (ja) | 2006-06-28 |
| CN1073557C (zh) | 2001-10-24 |
| CN1149288A (zh) | 1997-05-07 |
| JPH09510472A (ja) | 1997-10-21 |
| GB9405715D0 (en) | 1994-05-11 |
| HUT75520A (en) | 1997-05-28 |
| FI963754L (fi) | 1996-09-20 |
| NO309188B1 (no) | 2000-12-27 |
| DK0751932T3 (da) | 1999-11-15 |
| CA2185813A1 (en) | 1995-09-28 |
| CZ266096A3 (en) | 1997-06-11 |
| CZ290304B6 (cs) | 2002-07-17 |
| FI963754A0 (fi) | 1996-09-20 |
| ATE181063T1 (de) | 1999-06-15 |
| HU9602572D0 (en) | 1996-11-28 |
| WO1995025718A1 (en) | 1995-09-28 |
| FI112359B (fi) | 2003-11-28 |
| GR3031084T3 (en) | 1999-12-31 |
| IL113113A0 (en) | 1995-06-29 |
| NZ282453A (en) | 1997-04-24 |
| ZA952377B (en) | 1996-02-07 |
| NO963949D0 (no) | 1996-09-20 |
| KR970701692A (ko) | 1997-04-12 |
| EP0751932B1 (en) | 1999-06-09 |
| IL113113A (en) | 2001-03-19 |
| US5811562A (en) | 1998-09-22 |
| DE69510189D1 (de) | 1999-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9503190D0 (en) | Vitamin d amide derivatives | |
| TR199701531T1 (xx) | Ektoparazit �ld�r�c� bile�imler. | |
| ATE164837T1 (de) | Acetamidderivate und ihre verwendung als modifizierungsmittel des verhaltens der verdauung | |
| DE69125185D1 (de) | Einfluss von n,n,n-trimethylsphingosin auf die aktivität der protein-c-kinase, melanomzellwachstum in vitro, metastatisches potential in vivo und humane blutblättchenaggregation | |
| NO963949D0 (no) | Amidderivater av vitamin D | |
| FI960303A0 (fi) | D-vitamiinianalogeja | |
| HUP0002392A2 (hu) | Növekedési hormon kiválasztását fokozó diazol-, oxazolszármazékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyászati készítmények | |
| ES465340A1 (es) | Procedimiento para la obtencion de derivados de amino-azu- car. | |
| DK0734376T3 (da) | Amino- og amidderivater af vitamin D | |
| NZ506139A (en) | Cholenic acid amides and pharmaceutical compositions thereof | |
| IL125926A0 (en) | Compounds related to the amidinium family pharmaceutical compositions containing them and uses thereof | |
| EP1061070A4 (en) | DERIVATIVES OF 24-HYDROXYVITAMIN D | |
| ES451484A1 (es) | Procedimiento para la obtencion de derivados de n-(1, 2, 4- triacin-5, on-4-il)oliuna. | |
| GB9806358D0 (en) | Synthesis of carboxylic acid derivatives | |
| DE69306760D1 (de) | Säureanhydride, ihre herstellung und ihre verwendung |